lifestyle.californiaconsumerbanking.com

Author: Lyell Immunopharma, Inc

Lyell Immunopharma Announces Participation in May Investor Conferences

May 12, 2026
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

May 9, 2026
Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference

May 5, 2026
Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer

May 3, 2026
Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

May 1, 2026
Lyell Immunopharma Announces Participation in March Investor Conferences

April 28, 2026
Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma

March 10, 2026